Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients

Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients

Abstract Introduction Current knowledge on the use of extracorporeal membrane oxygenation (ECMO) in COVID‐19 remains limited to small series and registry data. In the present retrospective monocentric study, we report on our experience, our basic principles, and our results in establishing and manag...

Full description

Bibliographic Details
Main Authors: Raphaël Giraud, David Legouis, Benjamin Assouline, Amandine De Charriere, Dumeng Decosterd, Marie‐Eve Brunner, Mallory Moret‐Bochatay, Thierry Fumeaux, Karim Bendjelid
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Physiological Reports
Subjects:
ARDS
COVID‐19 pandemic
VV‐ECMO
Online Access:https://doi.org/10.14814/phy2.14715

Internet

https://doi.org/10.14814/phy2.14715

Similar Items